These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18780291)

  • 21. From utopia to reality: increased survival in peritoneal carcinomatosis treated with cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Segura-Sampedro JJ; Morales-Soriano R
    Rev Esp Enferm Dig; 2017 Nov; 109(11):805. PubMed ID: 29032693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis: if at first you don't succeed...
    Lambert LA; Mansfield PF
    Ann Surg Oncol; 2007 Nov; 14(11):3037-9. PubMed ID: 17726635
    [No Abstract]   [Full Text] [Related]  

  • 23. Problems of success and problems of failure: recurrent disease after cytoreductive surgery and intraperitoneal chemoperfusion.
    Levine EA
    Ann Surg Oncol; 2004 Apr; 11(4):351-3. PubMed ID: 15070590
    [No Abstract]   [Full Text] [Related]  

  • 24. [Surgical treatment of peritoneal carcinomatosis].
    Elias D; Liberale G; Manganas D; Lasser P; Pocard M
    Ann Chir; 2004 Nov; 129(9):530-3. PubMed ID: 15556586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
    Virzi S; Iusco D; Grassi A; Navarra G; Ismail I; Panetta A; Bonomi S
    Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
    Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
    Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locoregional treatment of peritoneal carcinomatosis from gastric cancer.
    Bozzetti F; Yu W; Baratti D; Kusamura S; Deraco M
    J Surg Oncol; 2008 Sep; 98(4):273-6. PubMed ID: 18726891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of peritoneal carcinomatosis of non-gynecological origin].
    Bagnenko SF; Rukhliada NV; Grinev MV; Beliaev AM
    Vestn Khir Im I I Grek; 2002; 161(6):94-9. PubMed ID: 12638508
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.
    Bijelic L; Yan TD; Sugarbaker PH
    J Surg Oncol; 2008 Sep; 98(4):295-9. PubMed ID: 18726900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal carcinomatosis from colorectal cancer: the need for improving selection criteria for cytoreductive surgery and intraperitoneal chemotherapy.
    Aguiar S
    J Surg Oncol; 2010 Nov; 102(6):563-4. PubMed ID: 20976728
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytoreductive surgery for peritoneal malignancies--development of standards of care for the community.
    Esquivel J
    Surg Oncol Clin N Am; 2007 Jul; 16(3):653-66, x. PubMed ID: 17606199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal carcinomatosis of colorectal origin: recent advances and future evolution toward a curative treatment.
    Elias D; Goere D
    Recent Results Cancer Res; 2007; 169():115-22. PubMed ID: 17506255
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cancers of the stomach and peritoneal carcinoses: will hyperthermia be a new therapeutic approach?].
    Gilly FN; Carry PY; Sayag AC; Panteix GG; Bienvenu J; Brachet A; Salle B; Braillon G
    Ann Chir; 1993; 47(5):414-8. PubMed ID: 8215164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal carcinomatosis of colorectal origin: standard of care.
    Yan TD
    Ann Surg; 2006 Oct; 244(4):632-3; author reply 633-4. PubMed ID: 16998376
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a panacea or just an obstacle course for the patient?
    Khatri VP
    J Clin Oncol; 2010 Jan; 28(1):5-7. PubMed ID: 19917856
    [No Abstract]   [Full Text] [Related]  

  • 36. [Peritoneal carcinomatosis. Surgical treatment, peritonectomy and intraperitoneal chemohyperthermia].
    Glehen O; Beaujard AC; Arvieux C; Huber O; Gilly FN
    Gastroenterol Clin Biol; 2002 Mar; 26(3):210-5. PubMed ID: 11981459
    [No Abstract]   [Full Text] [Related]  

  • 37. Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities.
    Knorr C; Reingruber B; Meyer T; Hohenberger W; Stremmel C
    Int J Colorectal Dis; 2004 May; 19(3):181-7. PubMed ID: 12955416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy.
    Verwaal VJ
    Cancer J; 2009; 15(3):212-5. PubMed ID: 19556907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new policy regarding ovarian resection in young women treated for peritoneal carcinomatosis.
    Elias D; Duchalais E; Dartigues P; Duvillard P; Poirot C; Goéré D
    Ann Surg Oncol; 2013 Jun; 20(6):1837-42. PubMed ID: 23370670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immuno-PCI: a proposal for the implementation of "seed and soil" concept in the treatment of peritoneal carcinomatosis from colorectal cancer.
    Seretis F; Seretis C
    Med Hypotheses; 2014 Aug; 83(2):137-41. PubMed ID: 24893828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.